TABLE 3.
Strain | MICs ofa:
|
|||||||
---|---|---|---|---|---|---|---|---|
Erythromycin
|
Rifampin
|
Chloramphenicol
|
Trimethoprim-sulfamethoxazole
|
|||||
BGA | RL−C | BGA | RL−C | BGA | RL−C | BGA | RL−C | |
S. aureus ATCC 29213b | 0.5–1.0 (1.0) | 0.5–1.0 (1.0) | 0.12–0.25 (0.12) | 0.12–0.25 (0.12) | 8 | 8–16 (8) | 0.06–0.125 (0.125) | 0.125 (0.125) |
B. pertussis ATCC 9797 | 0.06–0.12 (0.125) | 0.06–0.12 (0.12) | 2.0–4.0 (2) | 2.0–4.0 (2) | 0.12–0.5 (0.5) | 0.12–2.0 (1) | 0.008–0.06 (0.06) | 0.016–0.06 (0.06) |
B. pertussis CDC-B100 | >256 | >256 | 2.0–8.0 (2) | 2.0–8.0 (2) | 0.5–1.0 (0.5) | 1.0–2.0 (1) | 0.008–0.12 (0.06) | 0.004–0.12 (0.06) |
Results are given in micrograms per milliliter. Modes are shown in parentheses.
NCCLS quality control ranges for S. aureus ATCC 29213 are as follows: erythromycin, 0.25 to 1.0 μg/ml; rifampin, 0.004 to 0.015 μg/ml; chloramphenicol, 2 to 8 μg/ml; and trimethoprim-sulfamethoxazole, ≤0.5/9.5 μg/ml.